Immediate Impact
2 from Science/Nature 90 standout
Citing Papers
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Melissa Langer being referenced
CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Melissa Langer | 279 | 23 | 281 | 78 | 10 | 397 | |
| Renata Lottici | 118 | 51 | 295 | 44 | 9 | 384 | |
| Wolfgang Stiglbauer | 111 | 14 | 147 | 69 | 9 | 381 | |
| Gwendoline Soler | 200 | 14 | 150 | 96 | 14 | 409 | |
| Xin-Ke Zhang | 111 | 75 | 210 | 54 | 9 | 347 | |
| Rodrigo C. Guimarães | 254 | 5 | 282 | 80 | 8 | 391 | |
| Nhu Le | 172 | 29 | 128 | 57 | 7 | 367 | |
| Allen B. Tu | 159 | 62 | 134 | 51 | 10 | 402 | |
| James O. Morse | 132 | 18 | 111 | 186 | 7 | 403 | |
| Phillip George | 137 | 20 | 112 | 16 | 10 | 450 | |
| Joana Sederias | 100 | 19 | 119 | 52 | 9 | 424 |
All Works
Loading papers...